Rac GTPases in Hematological Malignancies
Emerging evidence suggests that crosstalk between hematologic tumor cells and the tumor microenvironment contributes to leukemia and lymphoma cell migration, survival, and proliferation. The supportive tumor cell-microenvironment interactions and the resulting cellular processes require adaptations...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-12-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/19/12/4041 |
id |
doaj-60024e989bd6475c90b7a7942421f3a4 |
---|---|
record_format |
Article |
spelling |
doaj-60024e989bd6475c90b7a7942421f3a42020-11-24T20:44:37ZengMDPI AGInternational Journal of Molecular Sciences1422-00672018-12-011912404110.3390/ijms19124041ijms19124041Rac GTPases in Hematological MalignanciesValerie Durand-Onaylı0Theresa Haslauer1Andrea Härzschel2Tanja Nicole Hartmann3Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectious Disease, Rheumatology, Oncologic Center, Salzburg Cancer Research Institute—Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Cancer Cluster Salzburg, 5020 Salzburg, AustriaDepartment of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectious Disease, Rheumatology, Oncologic Center, Salzburg Cancer Research Institute—Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Cancer Cluster Salzburg, 5020 Salzburg, AustriaDepartment of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectious Disease, Rheumatology, Oncologic Center, Salzburg Cancer Research Institute—Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Cancer Cluster Salzburg, 5020 Salzburg, AustriaDepartment of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectious Disease, Rheumatology, Oncologic Center, Salzburg Cancer Research Institute—Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Cancer Cluster Salzburg, 5020 Salzburg, AustriaEmerging evidence suggests that crosstalk between hematologic tumor cells and the tumor microenvironment contributes to leukemia and lymphoma cell migration, survival, and proliferation. The supportive tumor cell-microenvironment interactions and the resulting cellular processes require adaptations and modulations of the cytoskeleton. The Rac subfamily of the Rho family GTPases includes key regulators of the cytoskeleton, with essential functions in both normal and transformed leukocytes. Rac proteins function downstream of receptor tyrosine kinases, chemokine receptors, and integrins, orchestrating a multitude of signals arising from the microenvironment. As such, it is not surprising that deregulation of Rac expression and activation plays a role in the development and progression of hematological malignancies. In this review, we will give an overview of the specific contribution of the deregulation of Rac GTPases in hematologic malignancies.https://www.mdpi.com/1422-0067/19/12/4041Rac GTPasesleukemialymphomamicroenvironmentcancermigrationsurvivalproliferation |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Valerie Durand-Onaylı Theresa Haslauer Andrea Härzschel Tanja Nicole Hartmann |
spellingShingle |
Valerie Durand-Onaylı Theresa Haslauer Andrea Härzschel Tanja Nicole Hartmann Rac GTPases in Hematological Malignancies International Journal of Molecular Sciences Rac GTPases leukemia lymphoma microenvironment cancer migration survival proliferation |
author_facet |
Valerie Durand-Onaylı Theresa Haslauer Andrea Härzschel Tanja Nicole Hartmann |
author_sort |
Valerie Durand-Onaylı |
title |
Rac GTPases in Hematological Malignancies |
title_short |
Rac GTPases in Hematological Malignancies |
title_full |
Rac GTPases in Hematological Malignancies |
title_fullStr |
Rac GTPases in Hematological Malignancies |
title_full_unstemmed |
Rac GTPases in Hematological Malignancies |
title_sort |
rac gtpases in hematological malignancies |
publisher |
MDPI AG |
series |
International Journal of Molecular Sciences |
issn |
1422-0067 |
publishDate |
2018-12-01 |
description |
Emerging evidence suggests that crosstalk between hematologic tumor cells and the tumor microenvironment contributes to leukemia and lymphoma cell migration, survival, and proliferation. The supportive tumor cell-microenvironment interactions and the resulting cellular processes require adaptations and modulations of the cytoskeleton. The Rac subfamily of the Rho family GTPases includes key regulators of the cytoskeleton, with essential functions in both normal and transformed leukocytes. Rac proteins function downstream of receptor tyrosine kinases, chemokine receptors, and integrins, orchestrating a multitude of signals arising from the microenvironment. As such, it is not surprising that deregulation of Rac expression and activation plays a role in the development and progression of hematological malignancies. In this review, we will give an overview of the specific contribution of the deregulation of Rac GTPases in hematologic malignancies. |
topic |
Rac GTPases leukemia lymphoma microenvironment cancer migration survival proliferation |
url |
https://www.mdpi.com/1422-0067/19/12/4041 |
work_keys_str_mv |
AT valeriedurandonaylı racgtpasesinhematologicalmalignancies AT theresahaslauer racgtpasesinhematologicalmalignancies AT andreaharzschel racgtpasesinhematologicalmalignancies AT tanjanicolehartmann racgtpasesinhematologicalmalignancies |
_version_ |
1716816762845003776 |